Sio Gene Therapies Inc.
SIOX · NASDAQ
3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 | |
|---|---|---|---|---|
| Market Cap | $49 | $136 | $61 | $162 |
| - Cash | $64 | $119 | $81 | $107 |
| + Debt | $3 | $1 | $16 | $44 |
| Enterprise Value | -$12 | $18 | -$4 | $99 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$71 | -$29 | $0 | -$119 |
| % Margin | – | – | – | – |
| Net Income | -$72 | -$32 | -$73 | -$129 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.98 | -0.62 | -2.93 | -8.02 |
| % Growth | -58.1% | 78.8% | 63.5% | – |
| Operating Cash Flow | -$60 | -$47 | -$67 | -$134 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$61 | -$47 | -$68 | -$134 |